In this issue:
PRLs and the development of MS
Thymectomy versus medical treatment alone
Performance of 2024 McDonald criteria
Outcomes of anti-CD19 CAR-T cells in B-cell-dependent EAE models
CTLA4 expression in thymoma
Efficacy and safety of ocrelizumab
Optimal timing for treatment discontinuation
Feasibility of RATS thymectomy for late-onset MG patients
Distinguishing MRI characteristics of MOGAD and MS
Impact of pregnancy on MG
Please login below to download this issue (PDF)